|
Aug 30
|
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
|
|
Aug 29
|
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) in Egypt
|
|
Aug 22
|
Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
|